Next Article in Journal
Influence of Storage Temperature on Radiochemical Purity of 99mTc-Radiopharmaceuticals
Next Article in Special Issue
Response of Plant Secondary Metabolites to Environmental Factors
Previous Article in Journal
A Novel Approach for Microbial Synthesis of Enantiomerically Pure Whisky Lactones Based on Solid-State Fermentation
Previous Article in Special Issue
Comparison of Inhibitory Capacities of 6-, 8- and 10-Gingerols/Shogaols on the Canonical NLRP3 Inflammasome-Mediated IL-1β Secretion
Open AccessReview

Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops

Department of Biotechnology, University of Chemistry and Technology, Prague, Technická 5, 166 28 Prague 6, Czech Republic
*
Author to whom correspondence should be addressed.
Molecules 2018, 23(3), 660; https://doi.org/10.3390/molecules23030660
Received: 23 February 2018 / Revised: 11 March 2018 / Accepted: 14 March 2018 / Published: 15 March 2018
(This article belongs to the Special Issue Biological Activity of Secondary Metabolites)
Hop (Humulus lupulus L.), as a key ingredient for beer brewing, is also a source of many biologically active molecules. A notable compound, 8-prenylnaringenin (8-PN), structurally belonging to the group of prenylated flavonoids, was shown to be a potent phytoestrogen, and thus, became the topic of active research. Here, we overview the pharmacological properties of 8-PN and its therapeutic opportunities. Due to its estrogenic effects, administration of 8-PN represents a novel therapeutic approach to the treatment of menopausal and post-menopausal symptoms that occur as a consequence of a progressive decline in hormone levels in women. Application of 8-PN in the treatment of menopause has been clinically examined with promising results. Other activities that have already been assessed include the potential to prevent bone-resorption or inhibition of tumor growth. On the other hand, the use of phytoestrogens is frequently questioned regarding possible adverse effects associated with long-term consumption. In conclusion, we emphasize the implications of using 8-PN in future treatments of menopausal and post-menopausal symptoms, including the need for precise evidence and further investigations to define the safety risks related to its therapeutic use. View Full-Text
Keywords: 8-prenylnaringenin; menopause; hops; phytoestrogens 8-prenylnaringenin; menopause; hops; phytoestrogens
Show Figures

Figure 1

MDPI and ACS Style

Štulíková, K.; Karabín, M.; Nešpor, J.; Dostálek, P. Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops. Molecules 2018, 23, 660. https://doi.org/10.3390/molecules23030660

AMA Style

Štulíková K, Karabín M, Nešpor J, Dostálek P. Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops. Molecules. 2018; 23(3):660. https://doi.org/10.3390/molecules23030660

Chicago/Turabian Style

Štulíková, Kateřina; Karabín, Marcel; Nešpor, Jakub; Dostálek, Pavel. 2018. "Therapeutic Perspectives of 8-Prenylnaringenin, a Potent Phytoestrogen from Hops" Molecules 23, no. 3: 660. https://doi.org/10.3390/molecules23030660

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop